![]() |
市場調查報告書
商品編碼
1858886
藻類ω-3生產系統市場機會、成長促進因素、產業趨勢分析及預測Algae-Based Omega-3 Production Systems Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast |
||||||
2024 年全球藻類基 Omega-3 生產系統市場價值為 38 億美元,預計到 2034 年將以 18.2% 的複合年成長率成長至 202 億美元。

這一成長主要源於消費者對永續的植物性omega-3脂肪酸的需求不斷成長,將其作為傳統魚油的替代品。隨著健康意識、環境問題和飲食限制的日益普及,越來越多的人開始選擇藻類來源的omega-3,這類產品符合清潔標籤標準,且不含過敏原。藻類生物技術的進步,包括閉迴路系統和光生物反應器,顯著提高了生產效率和規模化能力。這些系統能夠實現更高的生質能產量,並提供可控的環境,最大限度地降低污染風險,確保產品一致性。消費者正敦促企業提供透明、無過敏原且符合環保價值的產品。草藥和植物性保健品的日益流行在美國尤為明顯,草藥類產品的年成長率高達5.4%,這持續支撐著對藻類來源omega-3的需求。隨著全球健康趨勢的不斷增強,各公司正競相在技術和產品配方方面進行創新,以滿足不斷成長的需求。
| 市場範圍 | |
|---|---|
| 起始年份 | 2024 |
| 預測年份 | 2025-2034 |
| 起始值 | 38億美元 |
| 預測值 | 202億美元 |
| 複合年成長率 | 18.2% |
異養發酵系統市佔率高達64.4%,預計2034年將維持18.2%的複合年成長率。這些系統已被證明是商業化生產藻類ω-3脂肪酸最可行、最具規模化的潛力。在受控條件下,異養發酵使藻類能夠代謝葡萄糖、蔗糖或工業副產品等碳水化合物來源,從而獲得最佳的ω-3脂肪酸產量。其工業規模相容性和降低環境污染風險的特性,使其成為主要產業參與者生產的核心技術。
2024年,膳食補充劑市佔率達到31.7%,隨著越來越多的消費者重視植物性健康產品,該領域正蓬勃發展。強大的零售網路、值得信賴的品牌以及可觀的利潤率,使該領域成為藻類來源的omega-3脂肪酸的主要應用領域。人們對omega-3脂肪酸健康益處的認知不斷提高,尤其是在心血管、認知和發炎健康方面,進一步推動了補充劑的消費。
受健康意識增強的消費者群體和植物性生活方式日益普及的推動,北美藻類ω-3生產系統市場預計將在2025年至2034年間以18.3%的複合年成長率成長。以非基因改造、有機和環保配方為中心的創新產品持續吸引尋求永續健康解決方案的消費者的注意。
全球藻類ω-3生產系統市場的主要企業包括DSM-Firmenich、Fermentalg、Cellana Inc.、Algatech、CABIO Biotech、Evonik Industries AG、Nuseed、Corbion NV、Algisys、Qualitas Health和Mara Renewables Corporation。這些企業正採取多種策略來鞏固和擴大市場佔有率。主要參與者正大力投資研發,以改善菌株選擇並提高脂質產量,同時最佳化異養發酵等生產技術,以實現成本效益高的規模化生產。與營養品和製藥品牌的合作有助於拓展分銷管道,並提高產品知名度。此外,各公司也在努力取得清潔標籤認證,並符合非基因改造、無過敏原和純素食標準,以搶佔細分市場。
(註:貿易統計僅針對重點國家提供)
The Global Algae-Based Omega-3 Production Systems Market was valued at USD 3.8 billion in 2024 and is estimated to grow at a CAGR of 18.2% to reach USD 20.2 billion by 2034.

This growth is driven by rising consumer demand for sustainable, plant-based omega-3 fatty acids as alternatives to traditional fish oil. With increasing health awareness, environmental concerns, and dietary restrictions, more individuals are turning toward algae-derived omega-3s, which meet clean-label standards and avoid allergens. Advances in algal biotechnology, including closed-loop systems and photobioreactors, are significantly enhancing production efficiency and scalability. These systems enable higher biomass yields and offer a controlled environment that minimizes contamination risks and ensures product consistency. Consumers are pushing companies to deliver transparent, allergen-free products that align with eco-conscious values. The rising popularity of herbal and plant-based health supplements is evident in the U.S., with an annual 5.4% growth in the herbals category, which continues to support demand for algae-derived omega-3. As the global wellness trend grows stronger, companies are racing to innovate in both technology and product formulation to meet this rising demand.
| Market Scope | |
|---|---|
| Start Year | 2024 |
| Forecast Year | 2025-2034 |
| Start Value | $3.8 Billion |
| Forecast Value | $20.2 Billion |
| CAGR | 18.2% |
The heterotrophic fermentation systems segment held 64.4% share and is projected to maintain a CAGR of 18.2% through 2034. These systems have proven to be the most viable and scalable method for commercial algae-based omega-3 production. Operating under controlled conditions, heterotrophic fermentation allows algae to metabolize carbohydrate sources such as glucose, sucrose, or industrial byproducts for optimal omega-3 yield. Their industrial-scale compatibility and reduced risk of environmental contamination have positioned them as the backbone of production for key industry players.
The dietary supplements segment held a 31.7% share in 2024 and is gaining traction as more consumers prioritize plant-based health products. This segment benefits from strong retail networks, trusted brand names, and attractive margins, which make it a primary application area for algae-derived omega-3s. The increased awareness of omega-3's health benefits, particularly in cardiovascular, cognitive, and inflammatory health, is further supporting supplement uptake.
North America Algae-Based Omega-3 Production Systems Market is forecast to grow at a CAGR of 18.3% between 2025 and 2034, driven by a health-conscious consumer base and increasing adoption of plant-forward lifestyles. Innovations centered around non-GMO, organic, and environmentally friendly formulations continue to attract attention from consumers seeking sustainable wellness solutions.
Leading companies operating in the Global Algae-Based Omega-3 Production Systems Market include DSM-Firmenich, Fermentalg, Cellana Inc., Algatech, CABIO Biotech, Evonik Industries AG, Nuseed, Corbion N.V., Algisys, Qualitas Health, and Mara Renewables Corporation. Companies in the Global Algae-Based Omega-3 Production Systems Market are pursuing multiple strategies to secure and grow their market share. Key players are heavily investing in R&D to improve strain selection and boost lipid yield, while optimizing production technologies like heterotrophic fermentation for cost-effective scalability. Collaborations with nutrition and pharmaceutical brands help expand distribution channels and increase product visibility. Firms are also working toward obtaining clean-label certifications and aligning with non-GMO, allergen-free, and vegan-friendly standards to capture niche markets.
( Note: the trade statistics will be provided for key countries only)